| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Improve, nourish and elevate with organic-certified mushroom coffee, vegan superfoods, herbal tinctures, cocoa, and other exceptional plant-based products.
HFMA is the nation`s premier membership organization for more than 34000 healthcare financial management professionals employed by hospitals, integrated delivery systems, managed care organizations, ambulatory and long-term care facilities
Soda Health is a healthcare technology company focused on building solutions which eliminate health inequities and create a healthier America. Social Determinants of Health (SDOH) have a major impact on health and wellbeing, as well as the cost of care. Our mission is so important, we found a way to work SDOH into our company name.
The Windsor-Essex County Health Unit provides public health services to the residents and businesses of Windsor and Essex County in Ontario, Canada.